We are live on ! Find out more
SEM

Select Medical

Delisted

SEM was delisted on the 30th of June, 2026.

248 hedge funds and large institutions have $2.31B invested in Select Medical in 2023 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 90 increasing their positions, 89 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 25

1% more repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 89

0% more funds holding

Funds holding: 247 → 248 (+1)

0.06% more ownership

Funds ownership: 76.48% → 76.54% (+0.06%)

6% less capital invested

Capital invested by funds: $2.46B → $2.31B (-$151M)

65% less call options, than puts

Call options by funds: $126K | Put options by funds: $357K

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
248
Holders Change
+1
Holders Change %
+0.4%
% of All Funds
3.61%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
29
Increased
90
Reduced
89
Closed
25
Calls
$126K
Puts
$357K
Net Calls
-$231K
Net Calls Change
-$372K

SEM Hedge Fund Activity: Q4 2023 in Review

248 of the 6,872 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q4 2023, worth a combined $2.31B — down 6.1% from $2.46B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new SEM positions and 25 closed out — a net gain of 4 holders — while 90 added to existing stakes and 89 trimmed.

The largest buyer was BlackRock, adding an estimated $17.1M. The largest seller was Hood River Capital Management, cutting an estimated $40.4M.

  • 248 institutional investors held Select Medical (SEM) as of Q4 2023, up from 247 in Q3 2023.
  • Funds reported $2.31B of Select Medical stock for Q4 2023, down 6.1% quarter-over-quarter.
  • 29 funds opened new Select Medical positions in Q4 2023 and 25 closed out, a net change of +4 holders.
  • The largest Select Medical buyer in Q4 2023 was BlackRock, an estimated $17.1M added.
  • The largest Select Medical seller in Q4 2023 was Hood River Capital Management, an estimated $40.4M sold.

Based on aggregated 13F filings for Q4 2023.